96 related articles for article (PubMed ID: 18186261)
1. [Anti-steroid hormones for uterine cancer].
Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
3. [Antiestrogen therapy of patients with uterine cancer].
Sugimura M; Terao T
Nihon Rinsho; 1994 Mar; 52(3):804-8. PubMed ID: 8164386
[TBL] [Abstract][Full Text] [Related]
4. [Hormone therapy of endometrial carcinoma].
Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
7. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
[TBL] [Abstract][Full Text] [Related]
8. [Hormone therapy--recent advances].
Matsumoto K; Noguchi S
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2816-23. PubMed ID: 2959202
[TBL] [Abstract][Full Text] [Related]
9. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
11. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
[TBL] [Abstract][Full Text] [Related]
12. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
[TBL] [Abstract][Full Text] [Related]
13. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
[TBL] [Abstract][Full Text] [Related]
14. [New developments in hormonal therapy for breast cancer].
Tominaga T
Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
[TBL] [Abstract][Full Text] [Related]
15. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
16. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
[TBL] [Abstract][Full Text] [Related]
17. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal therapy in endometrial cancer].
Kanoh H; Okudaira Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2306-10. PubMed ID: 8259843
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
[TBL] [Abstract][Full Text] [Related]
20. [Growth of endometrial cancer and hormone].
Kanoh H; Hosono T; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
